On January 10, 2025, the Consumer Financial Protection Bureau (CFPB) revived its policy statements on No-Action Letters (NALs) and ...

In past years we have discussed how opioid-related enforcement efforts have remained a top federal and state priority (here, ...

IMPACT Therapeutics has received the China NMPA marketing authorisation for Senaparib capsules in treating ovarian cancer.

The global Engines and Gensets Outlook is anticipated to grow from estimated USD 401.95 billion in 2024 to USD 417.31 billion ...

Palisade Bio has begun the multiple ascending dose (MAD) cohorts of its ongoing Phase Ia/b trial of PALI-2108 for ulcerative ...

Nearly 50% of Gen Z plan on purchasing goods through a social media platform this year, according to a report from Sprout ...

Formation Metals, a North American mineral acquisition and exploration company, has announced the execution of an option ...

Avacta Therapeutics has reported outcomes from the Phase Ia trial of AVA6000, a drug candidate for solid tumours.

Nowadays, a standard application letter might not be enough to capture the attention of hiring managers. Crafting a unique ...

Loop Industries has reached a consensus with SK Geo Centric (SKGC) to mutually dissolve their joint venture (JV) agreement.

The CDE of China's NMPA has granted BTD to Innovent Biologics' IBI343 as a monotherapy treatment for CLDN18.2-positive PDAC ...

Rio Tinto and Glencore, two of the world's largest mining companies, recently engaged in brief merger discussions.